Financials
Value Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 1.59 M3.85 M3.69 M3.33 M 12.47 M Research & development 181.64 K397.14 K473.56 K611.3 K 1.66 M Operating income -2.26 M-4.22 M-2.19 M-4.1 M -12.77 M Non-Operating Income, Total -26.6 M0-163.8 K-366.51 K -27.13 M Interest expense, net of interest capitalized 168.76 K075.86 K365.25 K 609.88 K Non-Operating Income, excl. Interest Expenses -26.77 M0-239.66 K-731.76 K -27.74 M Unusual income/expense ———— — Pretax income -28.86 M-4.22 M-2.36 M-4.47 M -39.9 M Equity in earnings ———-1 256 — Taxes 0000 0 Non-controlling/minority interest ———— — After tax other income/expense ——-33.99 K-35.14 K — Net income before discontinued operations -28.86 M-4.22 M-2.36 M-4.47 M -39.9 M Discontinued operations ———— — Net income -28.86 M-4.22 M-2.36 M-4.47 M -39.9 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -28.86 M-4.22 M-2.36 M-4.47 M -39.9 M Basic earnings per share (Basic EPS) -2-0.150.48-0.15 -1.82 Diluted earnings per share (Diluted EPS) -2-0.150.48-0.15 -1.82 Average basic shares outstanding 14.41 M27.65 M20.58 M29.44 M — Diluted shares outstanding 14.41 M27.65 M20.58 M29.44 M — EBITDA -2.22 M-4.22 M-2.19 M-4.03 M -12.66 M EBIT -2.26 M-4.22 M-2.19 M-4.1 M -12.77 M Cost of revenue 67.19 K488.29 K2.56 M2 666 3.12 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) 31.64 K0068.51 K 100.15 K